{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:35:51Z","timestamp":1793900151069,"version":"4.8.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T00:00:00Z","timestamp":1421798400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s11102-015-0636-7","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T12:37:00Z","timestamp":1421757420000},"page":"752-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies"],"prefix":"10.1007","volume":"18","author":[{"given":"Cornelie D.","family":"Andela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet","family":"Scharloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad A.","family":"Kaptein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke R.","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,21]]},"reference":[{"key":"636_CR1","first-page":"100","volume-title":"Basic and clinical endocrinology","author":"D Gardner","year":"2011","unstructured":"Gardner D, Shoback D (2011) Basic and clinical endocrinology, 9th edn. McGrawHill, Singapore, pp 100\u2013101","edition":"9"},{"key":"636_CR2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/B978-0-444-59602-4.00024-1","volume":"124","author":"AM Pereira","year":"2014","unstructured":"Pereira AM (2014) Long-term effects of treatment of pituitary adenomas. Handb Clin Neurol 124:361\u2013371","journal-title":"Handb Clin Neurol"},{"key":"636_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7525-2-13","volume":"2","author":"X Badia","year":"2004","unstructured":"Badia X, Webb SM, Prieto L, Lara N (2004) Acromegaly Quality of Life Questionnaire (AcroQoL). Health Qual Life Outcomes 2:13","journal-title":"Health Qual Life Outcomes"},{"key":"636_CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.1.02214","volume":"155","author":"SM Webb","year":"2006","unstructured":"Webb SM, Badia X, Surinach NL (2006) Validity and clinical applicability of the acromegaly Quality of Life Questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol 155:269\u2013277","journal-title":"Eur J Endocrinol"},{"key":"636_CR5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2265.2002.01597.x","volume":"57","author":"SM Webb","year":"2002","unstructured":"Webb SM, Prieto L, Badia X, Albareda M, Catala M, Gaztambide S, Lucas T, Paramo C, Pico A, Lucas A, Halperin I, Obiols G, Astorga R (2002) Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol (Oxf) 57:251\u2013258","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR6","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1210\/jc.2003-030134","volume":"89","author":"M Rosilio","year":"2004","unstructured":"Rosilio M, Blum WF, Edwards DJ, Shavrikova EP, Valle D, Lamberts SW, Erfurth EM, Webb SM, Ross RJ, Chihara K, Henrich G, Herschbach P, Attanasio AF (2004) Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H). J Clin Endocrinol Metab 89:1684\u20131693","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008987922774","volume":"8","author":"SP McKenna","year":"1999","unstructured":"McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L, Wiren L (1999) The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 8:373\u2013383","journal-title":"Qual Life Res"},{"key":"636_CR8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1530\/EJE-07-0762","volume":"158","author":"SM Webb","year":"2008","unstructured":"Webb SM, Badia X, Barahona MJ, Colao A, Strasburger CJ, Tabarin A, van Aken MO, Pivonello R, Stalla G, Lamberts SW, Glusman JE (2008) Evaluation of health-related quality of life in patients with Cushing\u2019s syndrome with a new questionnaire. Eur J Endocrinol 158:623\u2013630","journal-title":"Eur J Endocrinol"},{"key":"636_CR9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2265.2011.04280.x","volume":"76","author":"M Milian","year":"2012","unstructured":"Milian M, Teufel P, Honegger J, Gallwitz B, Schnauder G, Psaras T (2012) The development of the Tuebingen Cushing\u2019s disease quality of life inventory (Tuebingen CD-25). Part II: normative data from 1784 healthy people. Clin Endocrinol (Oxf) 76:861\u2013867","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2265.2011.04191.x","volume":"76","author":"M Milian","year":"2012","unstructured":"Milian M, Teufel P, Honegger J, Gallwitz B, Schnauder G, Psaras T (2012) The development of the Tuebingen Cushing\u2019s disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties. Clin Endocrinol (Oxf) 76:851\u2013860","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR11","volume-title":"Health psychology","author":"D French","year":"2010","unstructured":"French D, Vedhara K, Kaptein AA, Weinman J (2010) Health psychology, 2nd edn. BPS Blackwell, Chichester","edition":"2"},{"key":"636_CR12","unstructured":"Bowling A (2001) Measuring disease. Open University Press, Maidenhead, p 16\u201318"},{"key":"636_CR13","first-page":"16","volume-title":"Quality of life assessments in clinical trials","author":"H Schipper","year":"1990","unstructured":"Schipper H, Clinch JJ, Olweny CLM (1990) Quality of life studies: definitions and conceptual issues. In: Spilker B (ed) Quality of life assessments in clinical trials. Raven Press Ltd, New York, p 16"},{"key":"636_CR14","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1210\/jc.2004-1565","volume":"90","author":"SV Rowles","year":"2005","unstructured":"Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90:3337\u20133341","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2265.2007.02891.x","volume":"67","author":"AN Paisley","year":"2007","unstructured":"Paisley AN, Rowles SV, Roberts ME, Webb SM, Badia X, Prieto L, Shalet SM, Trainer PJ (2007) Treatment of acromegaly improves quality of life, measured by AcroQol. Clin Endocrinol (Oxf) 67:358\u2013362","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR16","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s11136-013-0396-7","volume":"22","author":"X Badia","year":"2013","unstructured":"Badia X, Roset M, Valassi E, Franz H, Forsythe A, Webb SM (2013) Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing\u2019s syndrome (ERCUSYN). Qual Life Res 22:2941\u20132950","journal-title":"Qual Life Res"},{"key":"636_CR17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40271-013-0012-5","volume":"6","author":"LM Nelson","year":"2013","unstructured":"Nelson LM, Forsythe A, McLeod L, Pulgar S, Maldonado M, Coles T, Zhang Y, Webb SM, Badia X (2013) Psychometric evaluation of the Cushing\u2019s Quality-of-Life questionnaire. Patient 6:113\u2013124","journal-title":"Patient"},{"key":"636_CR18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40271-013-0010-7","volume":"6","author":"M Roset","year":"2013","unstructured":"Roset M, Badia X, Forsythe A, Webb SM (2013) Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing\u2019s syndrome. Patient 6:103\u2013111","journal-title":"Patient"},{"key":"636_CR19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/EJE-12-0325","volume":"167","author":"A Santos","year":"2012","unstructured":"Santos A, Resmini E, Martinez-Momblan MA, Crespo I, Valassi E, Roset M, Badia X, Webb SM (2012) Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice. Eur J Endocrinol 167:337\u2013342","journal-title":"Eur J Endocrinol"},{"key":"636_CR20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000355622","volume":"98","author":"M Milian","year":"2013","unstructured":"Milian M, Honegger J, Teufel P, Wolf A, Psaras T (2013) Tuebingen CD-25 is a sensitive tool to investigate health-related quality of life in Cushing\u2019s disease patients in the course of the disease. Neuroendocrinology 98:188\u2013199","journal-title":"Neuroendocrinology"},{"key":"636_CR21","first-page":"1905","volume":"86","author":"AL Barkan","year":"2001","unstructured":"Barkan AL (2001) The \u201cquality of life-assessment of growth hormone deficiency in adults\u201d questionnaire: can it be used to assess quality of life in hypopituitarism? J Clin Endocrinol Metab 86:1905\u20131907","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1524-4733.2000.34003.x","volume":"3","author":"WR Lenderking","year":"2000","unstructured":"Lenderking WR, Zacker C, Katznelson L, Vance ML, Hossain S, Tafesse E, Guacaneme AO, Pashos CL (2000) The reliability and validity of the impact on lifestyle questionnaire in patients with acromegaly. Value Health 3:261\u2013269","journal-title":"Value Health"},{"key":"636_CR23","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1210\/jc.2012-1235","volume":"97","author":"J Tiemensma","year":"2012","unstructured":"Tiemensma J, Daskalakis NP, van der Veen EM, Ramondt S, Richardson SK, Broadbent E, Romijn JA, Pereira AM, Biermasz NR, Kaptein AA (2012) Drawings reflect a new dimension of the psychological impact of long-term remission of Cushing\u2019s syndrome. J Clin Endocrinol Metab 97:3123\u20133131","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR24","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.surg.2008.08.024","volume":"144","author":"RS Sippel","year":"2008","unstructured":"Sippel RS, Elaraj DM, Kebebew E, Lindsay S, Tyrrell JB, Duh QY (2008) Waiting for change: symptom resolution after adrenalectomy for Cushing\u2019s syndrome. Surgery 144:1054\u20131060","journal-title":"Surgery"},{"key":"636_CR25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-2796.1999.00483.x","volume":"245","author":"L Pikkarainen","year":"1999","unstructured":"Pikkarainen L, Sane T, Reunanen A (1999) The survival and well-being of patients treated for Cushing\u2019s syndrome. J Intern Med 245:463\u2013468","journal-title":"J Intern Med"},{"key":"636_CR26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s002689910020","volume":"24","author":"SK Nagesser","year":"2000","unstructured":"Nagesser SK, van Seters AP, Kievit J, Hermans J, Krans HM, van de Velde CJ (2000) Long-term results of total adrenalectomy for Cushing\u2019s disease. World J Surg 24:108\u2013113","journal-title":"World J Surg"},{"key":"636_CR27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/EJE-07-0259","volume":"157","author":"M Kars","year":"2007","unstructured":"Kars M, van der Klaauw AA, Onstein CS, Pereira AM, Romijn JA (2007) Quality of life is decreased in female patients treated for microprolactinoma. Eur J Endocrinol 157:133\u2013139","journal-title":"Eur J Endocrinol"},{"key":"636_CR28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11102-008-0091-9","volume":"11","author":"NE Cesar de Oliveira","year":"2008","unstructured":"Cesar de Oliveira NE, Violante AHD, Caldas D, Lamounier FA, Rezende LC, Fontes R, Schrank Y, de Gomes SR, Vaisman M, Guerra E, Sebastian A, Colao A (2008) Quality of life in women with microprolactinoma treated with dopamine agonists. Pituitary 11:247\u2013254","journal-title":"Pituitary"},{"key":"636_CR29","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2265.2007.02951.x","volume":"67","author":"N Sonino","year":"2007","unstructured":"Sonino N, Ruini C, Navarrini C, Ottolini F, Sirri L, Paoletta A, Fallo F, Boscaro M, Fava GA (2007) Psychosocial impairment in patients treated for pituitary disease: a controlled study. Clin Endocrinol 67:719\u2013726","journal-title":"Clin Endocrinol"},{"key":"636_CR30","doi-asserted-by":"crossref","first-page":"675310","DOI":"10.5402\/2012\/675310","volume":"2012","author":"A Raappana","year":"2012","unstructured":"Raappana A, Pirila T, Ebeling T, Salmela P, Sintonen H, Koivukangas J (2012) Long-term health-related quality of life of surgically treated pituitary adenoma patients: a descriptive study. ISRN Endocrinol 2012:675310","journal-title":"ISRN Endocrinol"},{"key":"636_CR31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","volume":"6","author":"MD Johnson","year":"2003","unstructured":"Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6:81\u201387","journal-title":"Pituitary"},{"key":"636_CR32","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1210\/jc.2006-0003","volume":"91","author":"OM Dekkers","year":"2006","unstructured":"Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F, Smit JW, Romijn JA (2006) Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:3364\u20133369","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR33","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1210\/jc.2010-2742","volume":"96","author":"NR Biermasz","year":"2011","unstructured":"Biermasz NR, Joustra SD, Donga E, Pereira AM, van Duinen N, van Dijk M, van der Klaauw AA, Corssmit EP, Lammers GJ, van Kralingen KW, van Dijk JG, Romijn JA (2011) Patients previously treated for nonfunctioning pituitary macroadenomas have disturbed sleep characteristics, circadian movement rhythm, and subjective sleep quality. J Clin Endocrinol Metab 96:1524\u20131532","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2265.2012.04449.x","volume":"78","author":"C Capatina","year":"2013","unstructured":"Capatina C, Christodoulides C, Fernandez A, Cudlip S, Grossman AB, Wass JA, Karavitaki N (2013) Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomas. Clin Endocrinol (Oxf) 78:86\u201393","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11102-007-0018-x","volume":"10","author":"EH Nielsen","year":"2007","unstructured":"Nielsen EH, Lindholm J, Laurberg P, Bjerre P, Christiansen JS, Hagen C, Juul S, Jorgensen J, Kruse A, Stochholm K (2007) Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function. Pituitary 10:67\u201373","journal-title":"Pituitary"},{"key":"636_CR36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2265.1997.1400957.x","volume":"46","author":"RC Page","year":"1997","unstructured":"Page RC, Hammersley MS, Burke CW, Wass JA (1997) An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clin Endocrinol (Oxf) 46:401\u2013406","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.apmr.2004.05.018","volume":"86","author":"FF Casanueva","year":"2005","unstructured":"Casanueva FF, Leal A, Koltowska-Haggstrom M, Jonsson P, Goth MI (2005) Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: a KIMS-based study. Arch Phys Med Rehabil 86:463\u2013468","journal-title":"Arch Phys Med Rehabil"},{"key":"636_CR38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ghir.2008.08.007","volume":"18","author":"I Kreitschmann-Andermahr","year":"2008","unstructured":"Kreitschmann-Andermahr I, Poll EM, Reineke A, Gilsbach JM, Brabant G, Buchfelder M, Fassbender W, Faust M, Kann PH, Wallaschofski H (2008) Growth hormone deficient patients after traumatic brain injury\u2014baseline characteristics and benefits after growth hormone replacement\u2014an analysis of the German KIMS database. Growth Horm IGF Res 18:472\u2013478","journal-title":"Growth Horm IGF Res"},{"key":"636_CR39","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1210\/jc.2005-0185","volume":"90","author":"J Verhelst","year":"2005","unstructured":"Verhelst J, Kendall-Taylor P, Erfurth EM, Price DA, Geffner M, Koltowska-Haggstrom M, Jonsson PJ, Wilton P, Abs R (2005) Baseline characteristics and response to 2\u00a0years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database). J Clin Endocrinol Metab 90:4636\u20134643","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12020-008-9112-8","volume":"34","author":"SK Mattoo","year":"2008","unstructured":"Mattoo SK, Bhansali AK, Gupta N, Grover S, Malhotra R (2008) Psychosocial morbidity in acromegaly: a study from India. Endocrine 34:17\u201322","journal-title":"Endocrine"},{"key":"636_CR41","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1210\/jc.2004-0669","volume":"89","author":"NR Biermasz","year":"2004","unstructured":"Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369\u20135376","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR42","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1007\/BF03347053","volume":"34","author":"T Psaras","year":"2011","unstructured":"Psaras T, Milian M, Hattermann V, Will BE, Tatagiba M, Honegger J (2011) Predictive factors for neurocognitive function and quality of life after surgical treatment for Cushing\u2019s disease and acromegaly. J Endocrinol Invest 34:e168\u2013e177","journal-title":"J Endocrinol Invest"},{"key":"636_CR43","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1210\/jc.2006-0676","volume":"91","author":"R Kauppinen-Makelin","year":"2006","unstructured":"Kauppinen-Makelin R, Sane T, Sintonen H, Markkanen H, Valimaki MJ, Loyttyniemi E, Niskanen L, Reunanen A, Stenman UH (2006) Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab 91:3891\u20133896","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1507\/endocrj.EJ12-0424","volume":"60","author":"O Celik","year":"2013","unstructured":"Celik O, Hatipoglu E, Akhan SE, Uludag S, Kadioglu P (2013) Acromegaly is associated with higher frequency of female sexual dysfunction: experience of a single center. Endocr J 60:753\u2013761","journal-title":"Endocr J"},{"key":"636_CR45","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1210\/jc.2010-0394","volume":"95","author":"J Leon-Carrion","year":"2010","unstructured":"Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-Lopez P, Galvez MA, Tinahones FJ, Leal-Cerro A (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J Clin Endocrinol Metab 95:4367\u20134379","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1460067","volume":"146","author":"U Feldt-Rasmussen","year":"2002","unstructured":"Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P, Wuster C (2002) Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing\u2019s disease. Eur J Endocrinol 146:67\u201374","journal-title":"Eur J Endocrinol"},{"key":"636_CR47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4158\/EP11134.OR","volume":"18","author":"E Valassi","year":"2012","unstructured":"Valassi E, Brick DJ, Johnson JC, Biller BM, Klibanski A, Miller KK (2012) Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders. Endocr Pract 18:209\u2013218","journal-title":"Endocr Pract"},{"key":"636_CR48","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11102-012-0452-2","volume":"16","author":"R Pas van der","year":"2012","unstructured":"van der Pas R, de Bruin C, Pereira AM, Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, de Jong FH, van der Lely AJ, de Herder WW, Webb SM, Lamberts SW, Hofland LJ, Feelders RA (2012) Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing\u2019s disease. Pituitary 16:536\u2013544","journal-title":"Pituitary"},{"key":"636_CR49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12020-009-9182-2","volume":"35","author":"SK Mattoo","year":"2009","unstructured":"Mattoo SK, Bhansali AK, Gupta N, Grover S, Malhotra R (2009) Psychosocial morbidity in Cushing disease: a study from India. Endocrine 35:306\u2013311","journal-title":"Endocrine"},{"key":"636_CR50","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3760\/cma.j.issn.0366-6999.2010.13.008","volume":"123","author":"XF Ding","year":"2010","unstructured":"Ding XF, Li HZ, Yan WG, Gao Y, Li XQ (2010) Role of adrenalectomy in recurrent Cushing\u2019s disease. Chin Med J (Engl) 123:1658\u20131662","journal-title":"Chin Med J (Engl)"},{"key":"636_CR51","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1067\/msy.2002.128482","volume":"132","author":"MT Hawn","year":"2002","unstructured":"Hawn MT, Cook D, Deveney C, Sheppard BC (2002) Quality of life after laparoscopic bilateral adrenalectomy for Cushing\u2019s disease. Surgery 132:1064\u20131068","journal-title":"Surgery"},{"key":"636_CR52","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11102-012-0425-5","volume":"16","author":"N Alcalar","year":"2012","unstructured":"Alcalar N, Ozkan S, Kadioglu P, Celik O, Cagatay P, Kucukyuruk B, Gazioglu N (2012) Evaluation of depression, quality of life and body image in patients with Cushing\u2019s disease. Pituitary 16:333\u2013340","journal-title":"Pituitary"},{"key":"636_CR53","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jc.2005-1058","volume":"91","author":"JR Lindsay","year":"2006","unstructured":"Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK (2006) Long-term impaired quality of life in Cushing\u2019s syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447\u2013453","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR54","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1210\/jc.2004-1375","volume":"90","author":"MO Aken van","year":"2005","unstructured":"van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW, Romijn JA (2005) Quality of life in patients after long-term biochemical cure of Cushing\u2019s disease. J Clin Endocrinol Metab 90:3279\u20133286","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2265.2006.02462.x","volume":"64","author":"N Sonino","year":"2006","unstructured":"Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA (2006) Personality characteristics and quality of life in patients treated for Cushing\u2019s syndrome. Clin Endocrinol (Oxf) 64:314\u2013318","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR56","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jamcollsurg.2009.02.054","volume":"208","author":"PW Smith","year":"2009","unstructured":"Smith PW, Turza KC, Carter CO, Vance ML, Laws ER, Hanks JB (2009) Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy. J Am Coll Surg 208:1059\u20131064","journal-title":"J Am Coll Surg"},{"key":"636_CR57","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-12-0308","volume":"167","author":"MA Wagenmakers","year":"2012","unstructured":"Wagenmakers MA, Netea-Maier RT, Prins JB, Dekkers T, den Heijer M, Hermus AR (2012) Impaired quality of life in patients in long-term remission of Cushing\u2019s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism? Eur J Endocrinol 167:687\u2013695","journal-title":"Eur J Endocrinol"},{"key":"636_CR58","first-page":"117","volume":"86","author":"J Lindholm","year":"2001","unstructured":"Lindholm J, Juul S, Jorgensen JOL, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen LO, Laurberg P, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing\u2019s syndrome: a population-based study. J Clin Endocrinol Metab 86:117\u2013123","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR59","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/EJE-12-1078","volume":"168","author":"SB Abraham","year":"2013","unstructured":"Abraham SB, Abel BS, Rubino D, Nansel T, Ramsey S, Nieman LK (2013) A direct comparison of quality of life in obese and Cushing\u2019s syndrome patients. Eur J Endocrinol 168:787\u2013793","journal-title":"Eur J Endocrinol"},{"key":"636_CR60","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-09-0836","volume":"162","author":"C Hoybye","year":"2010","unstructured":"Hoybye C, Ragnarsson O, Jonsson PJ, Koltowska-Haggstrom M, Trainer P, Feldt-Rasmussen U, Biller BM (2010) Clinical features of GH deficiency and effects of 3\u00a0years of GH replacement in adults with controlled Cushing\u2019s disease. Eur J Endocrinol 162:677\u2013684","journal-title":"Eur J Endocrinol"},{"key":"636_CR61","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.sla.0000251578.03883.2f","volume":"245","author":"SK Thompson","year":"2007","unstructured":"Thompson SK, Hayman AV, Ludlam WH, Deveney CW, Loriaux DL, Sheppard BC (2007) Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing\u2019s disease: a 10-year experience. Ann Surg 245:790\u2013794","journal-title":"Ann Surg"},{"key":"636_CR62","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00701-013-1809-7","volume":"155","author":"M Milian","year":"2013","unstructured":"Milian M, Honegger J, Gerlach C, Psaras T (2013) Health-related quality of life and psychiatric symptoms improve effectively within a short time in patients surgically treated for pituitary tumors\u2014a longitudinal study of 106 patients. Acta Neurochir (Wien) 155:1637\u20131645","journal-title":"Acta Neurochir (Wien)"},{"key":"636_CR63","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2265.2004.02118.x","volume":"61","author":"AH Heald","year":"2004","unstructured":"Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL (2004) Long-term negative impact on quality of life in patients with successfully treated Cushing\u2019s disease. Clin Endocrinol (Oxf) 61:458\u2013465","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR64","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2265.2008.03288.x","volume":"69","author":"AA Klaauw van der","year":"2008","unstructured":"van der Klaauw AA, Kars M, Biermasz NR, Roelfsema F, Dekkers OM, Corssmit EP, van Aken MO, Havekes B, Pereira AM, Pijl H, Smit JW, Romijn JA (2008) Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 69:775\u2013784","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00019514-200304000-00005","volume":"12","author":"A Baird","year":"2003","unstructured":"Baird A, Sullivan T, Zafar S, Rock J (2003) Quality of life in patients with pituitary tumors: a preliminary study. Qual Manag Health Care 12:97\u2013105","journal-title":"Qual Manag Health Care"},{"key":"636_CR66","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1590\/S0004-282X2010000300004","volume":"68","author":"A Pereira-Neto","year":"2010","unstructured":"Pereira-Neto A, Borba AM, Mello PA, Naves LA, Araujo AS Jr, Casulari LA (2010) Mean intrasellar pressure, visual field, headache intensity and quality of life of patients with pituitary adenoma. Arq Neuropsiquiatr 68:350\u2013354","journal-title":"Arq Neuropsiquiatr"},{"key":"636_CR67","unstructured":"Van der Zee KI, Sanderman R 2012 Het meten van de algemene gezondheidstoestand met de RAND-36, een handleiding (Manual SF-36, in Dutch). Noordelijk Centrum voor Gezondheidvraagstukken. Groningen, Rijks Universiteit Groningen"},{"key":"636_CR68","first-page":"265","volume":"163","author":"WM Hopman","year":"2000","unstructured":"Hopman WM, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, Joseph L, Brown JP, Murray TM, Adachi JD, Hanley DA, Papadimitropoulos E (2000) Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ 163:265\u2013271","journal-title":"CMAJ"},{"key":"636_CR69","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/14034948980260040401","volume":"26","author":"JH Loge","year":"1998","unstructured":"Loge JH, Kaasa S (1998) Short form 36 (SF-36) health survey: normative data from the general Norwegian population. Scand J Soc Med 26:250\u2013258","journal-title":"Scand J Soc Med"},{"key":"636_CR70","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1477-7525-4-91","volume":"4","author":"A Jorngarden","year":"2006","unstructured":"Jorngarden A, Wettergen L, von EL (2006) Measuring health-related quality of life in adolescents and young adults: Swedish normative data for the SF-36 and the HADS, and the influence of age, gender, and method of administration. Health Qual Life Outcomes 4:91","journal-title":"Health Qual Life Outcomes"},{"key":"636_CR71","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF03167695","volume":"169","author":"C Blake","year":"2000","unstructured":"Blake C, Codd MB, O\u2019Meara YM (2000) The short form 36 (SF-36) health survey: normative data for the Irish population. Ir J Med Sci 169:195\u2013200","journal-title":"Ir J Med Sci"},{"key":"636_CR72","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1590\/S1413-81232013000700006","volume":"18","author":"LN Cruz","year":"2013","unstructured":"Cruz LN, Fleck MP, Oliveira MR, Camey SA, Hoffmann JF, Bagattini AM, Polanczyk CA (2013) Health-related quality of life in Brazil: normative data for the SF-36 in a general population sample in the south of the country. Cien Saude Colet 18:1911\u20131921","journal-title":"Cien Saude Colet"},{"key":"636_CR73","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00701-012-1473-3","volume":"154","author":"E Tanemura","year":"2012","unstructured":"Tanemura E, Nagatani T, Aimi Y, Kishida Y, Takeuchi K, Wakabayashi T (2012) Quality of life in nonfunctioning pituitary macroadenoma patients before and after surgical treatment. Acta Neurochir (Wien) 154:1895\u20131902","journal-title":"Acta Neurochir (Wien)"},{"key":"636_CR74","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1210\/jc.2007-0944","volume":"92","author":"AA Klaauw van der","year":"2007","unstructured":"van der Klaauw AA, Dekkers OM, Pereira AM, van Kralingen KW, Romijn JA (2007) Increased daytime somnolence despite normal sleep patterns in patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 92:3898\u20133903","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR75","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2007.01.017","volume":"68","author":"AP Beek van","year":"2007","unstructured":"van Beek AP, van den Bergh AC, van den Berg LM, van den Berg G, Keers JC, Langendijk JA, Wolffenbuttel BH (2007) Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma. Int J Radiat Oncol Biol Phys 68:986\u2013991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"636_CR76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2265.2005.02307.x","volume":"63","author":"R Trepp","year":"2005","unstructured":"Trepp R, Everts R, Stettler C, Fischli S, Allemann S, Webb SM, Christ ER (2005) Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL). Clin Endocrinol (Oxf) 63:103\u2013110","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR77","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF03346555","volume":"33","author":"C Sardella","year":"2010","unstructured":"Sardella C, Lombardi M, Rossi G, Cosci C, Brogioni S, Scattina I, Webb SM, Gasperi M, Martino E, Bogazzi F (2010) Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study. J Endocrinol Invest 33:20\u201325","journal-title":"J Endocrinol Invest"},{"key":"636_CR78","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/EJE-07-0697","volume":"158","author":"MP Matta","year":"2008","unstructured":"Matta MP, Couture E, Cazals L, Vezzosi D, Bennet A, Caron P (2008) Impaired quality of life of patients with acromegaly: control of GH\/IGF-I excess improves psychological subscale appearance. Eur J Endocrinol 158:305\u2013310","journal-title":"Eur J Endocrinol"},{"key":"636_CR79","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1210\/jc.2008-2671","volume":"94","author":"T Wexler","year":"2009","unstructured":"Wexler T, Gunnell L, Omer Z, Kuhlthau K, Beauregard C, Graham G, Utz AL, Biller B, Nachtigall L, Loeffler J, Swearingen B, Klibanski A, Miller KK (2009) Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. J Clin Endocrinol Metab 94:2471\u20132477","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR80","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.1.01838","volume":"152","author":"IE Bonapart","year":"2005","unstructured":"Bonapart IE, van Domburg R, ten Have SM, de Herder WW, Erdman RA, Janssen JA, van der Lely AJ (2005) The \u2018bio-assay\u2019 quality of life might be a better marker of disease activity in acromegalic patients than serum total IGF-I concentrations. Eur J Endocrinol 152:217\u2013224","journal-title":"Eur J Endocrinol"},{"key":"636_CR81","first-page":"412","volume":"36","author":"O Celik","year":"2012","unstructured":"Celik O, Kadioglu P (2012) Quality of life in female patients with acromegaly. J Endocrinol Invest 36:412\u2013416","journal-title":"J Endocrinol Invest"},{"key":"636_CR82","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1530\/eje.1.02292","volume":"155","author":"SC Hua","year":"2006","unstructured":"Hua SC, Yan YH, Chang TC (2006) Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly. Eur J Endocrinol 155:831\u2013837","journal-title":"Eur J Endocrinol"},{"key":"636_CR83","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1530\/EJE-07-0356","volume":"157","author":"G T\u2019Sjoen","year":"2007","unstructured":"T\u2019Sjoen G, Bex M, Maiter D, Velkeniers B, Abs R (2007) Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly. Eur J Endocrinol 157:411\u2013417","journal-title":"Eur J Endocrinol"},{"key":"636_CR84","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11102-011-0298-z","volume":"14","author":"S Cannavo","year":"2011","unstructured":"Cannavo S, Condurso R, Ragonese M, Ferrau F, Alibrandi A, Arico I, Romanello G, Squadrito S, Trimarchi F, Silvestri R (2011) Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. Pituitary 14:328\u2013334","journal-title":"Pituitary"},{"key":"636_CR85","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ghir.2010.02.003","volume":"20","author":"MJ Wassenaar","year":"2010","unstructured":"Wassenaar MJ, Biermasz NR, Kloppenburg M, van der Klaauw AA, Tiemensma J, Smit JW, Pereira AM, Roelfsema F, Kroon HM, Romijn JA (2010) Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Horm IGF Res 20:226\u2013233","journal-title":"Growth Horm IGF Res"},{"key":"636_CR86","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1210\/jc.2004-2297","volume":"90","author":"NR Biermasz","year":"2005","unstructured":"Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F (2005) Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab 90:2731\u20132739","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR87","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/EJE-07-0838","volume":"158","author":"A Miller","year":"2008","unstructured":"Miller A, Doll H, David J, Wass J (2008) Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur J Endocrinol 158:587\u2013593","journal-title":"Eur J Endocrinol"},{"key":"636_CR88","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0030-1267912","volume":"119","author":"T Psaras","year":"2011","unstructured":"Psaras T, Honegger J, Gallwitz B, Milian M (2011) Are there gender-specific differences concerning quality of life in treated acromegalic patients? Exp Clin Endocrinol Diabetes 119:300\u2013305","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"636_CR89","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1530\/EJE-11-0657","volume":"165","author":"S Yamada","year":"2011","unstructured":"Yamada S, Fukuhara N, Nishioka H, Takeshita A, Suzuki H, Miyakawa M, Takeuchi Y (2011) GH deficiency in patients after cure of acromegaly by surgery alone. Eur J Endocrinol 165:873\u2013879","journal-title":"Eur J Endocrinol"},{"key":"636_CR90","first-page":"326","volume":"16","author":"S Fujio","year":"2013","unstructured":"Fujio S, Tokimura H, Hirano H, Hanaya R, Kubo F, Yunoue S, Bohara M, Kinoshita Y, Tominaga A, Arimura H, Arita K (2013) Severe growth hormone deficiency is rare in surgically-cured acromegalics. Pituitary 16:326\u2013332","journal-title":"Pituitary"},{"key":"636_CR91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.2007.03169.x","volume":"69","author":"AA Klaauw van der","year":"2008","unstructured":"van der Klaauw AA, Biermasz NR, Hoftijzer HC, Pereira AM, Romijn JA (2008) Previous radiotherapy negatively influences quality of life during 4\u00a0years of follow-up in patients cured from acromegaly. Clin Endocrinol (Oxf) 69:123\u2013128","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR92","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1530\/EJE-11-0853","volume":"166","author":"MR Postma","year":"2012","unstructured":"Postma MR, Netea-Maier RT, van den Berg G, Homan J, Sluiter WJ, Wagenmakers MA, van den Bergh AC, Wolffenbuttel BH, Hermus AR, van Beek AP (2012) Quality of life is impaired in association with the need for prolonged postoperative therapy by somatostatin analogs in patients with acromegaly. Eur J Endocrinol 166:585\u2013592","journal-title":"Eur J Endocrinol"},{"key":"636_CR93","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/EJE-10-0640","volume":"163","author":"KZ Rubeck","year":"2010","unstructured":"Rubeck KZ, Madsen M, Andreasen CM, Fisker S, Frystyk J, Jorgensen JOL (2010) Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery. Eur J Endocrinol 163:717\u2013726","journal-title":"Eur J Endocrinol"},{"key":"636_CR94","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11102-012-0447-z","volume":"16","author":"S Siegel","year":"2012","unstructured":"Siegel S, Streetz-van der Werf C, Schott JS, Nolte K, Karges W, Kreitschmann-Andermahr I (2012) Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary 16:507\u2013514","journal-title":"Pituitary"},{"key":"636_CR95","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1210\/jc.2011-1645","volume":"96","author":"J Tiemensma","year":"2011","unstructured":"Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR (2011) Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly. J Clin Endocrinol Metab 96:3550\u20133558","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR96","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","volume":"165","author":"E Valassi","year":"2011","unstructured":"Valassi E, Santos A, Yaneva M, Toth M, Strasburger CJ, Chanson P, Wass JA, Chabre O, Pfeifer M, Feelders RA, Tsagarakis S, Trainer PJ, Franz H, Zopf K, Zacharieva S, Lamberts SW, Tabarin A, Webb SM (2011) The European registry on Cushing\u2019s syndrome: 2-year experience. Baseline demographic and clinical characteristics. Eur J Endocrinol 165:383\u2013392","journal-title":"Eur J Endocrinol"},{"key":"636_CR97","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-11-0307","volume":"165","author":"J Tiemensma","year":"2011","unstructured":"Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR (2011) Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing\u2019s syndrome. Eur J Endocrinol 165:527\u2013535","journal-title":"Eur J Endocrinol"},{"key":"636_CR98","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000012326","volume":"68","author":"N Sonino","year":"1999","unstructured":"Sonino N, Scarpa E, Paoletta A, Fallo F, Boscaro M (1999) Slow-release lanreotide treatment in acromegaly: effects on quality of life. Psychother Psychosom 68:165\u2013167","journal-title":"Psychother Psychosom"},{"key":"636_CR99","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF03346453","volume":"32","author":"G Lombardi","year":"2009","unstructured":"Lombardi G, Minuto F, Tamburrano G, Ambrosio MR, Arnaldi G, Arosio M, Chiarini V, Cozzi R, Grottoli S, Mantero F, Bogazzi F, Terzolo M, Tita P, Boscani PF, Colao A (2009) Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly. J Endocrinol Invest 32:202\u2013209","journal-title":"J Endocrinol Invest"},{"key":"636_CR100","doi-asserted-by":"crossref","unstructured":"Mangupli R, Camperos P, Webb SM (2013) Biochemical and quality of life responses to octreotide-LAR in acromegaly. Pituitary 17:495\u2013499","DOI":"10.1007\/s11102-013-0533-x"},{"key":"636_CR101","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2265.2011.04106.x","volume":"75","author":"Z Karaca","year":"2011","unstructured":"Karaca Z, Tanriverdi F, Elbuken G, Cakir I, Donmez H, Selcuklu A, Durak AC, Dokmetas HS, Colak R, Unluhizarci K, Kelestimur F (2011) Comparison of primary octreotide-lar and surgical treatment in newly diagnosed patients with acromegaly. Clin Endocrinol (Oxf) 75:678\u2013684","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR102","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/BF03345774","volume":"32","author":"E Ghigo","year":"2009","unstructured":"Ghigo E, Biller BM, Colao A, Kourides IA, Rajicic N, Hutson RK, De ML, Klibanski A (2009) Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naive to radiation and medical therapy. J Endocrinol Invest 32:924\u2013933","journal-title":"J Endocrinol Invest"},{"key":"636_CR103","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2009.03620.x","volume":"71","author":"PJ Trainer","year":"2009","unstructured":"Trainer PJ, Ezzat S, D\u2019Souza GA, Layton G, Strasburger CJ (2009) A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly. Clin Endocrinol 71:549\u2013557","journal-title":"Clin Endocrinol"},{"key":"636_CR104","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1210\/jc.2008-0669","volume":"93","author":"SJ Neggers","year":"2008","unstructured":"Neggers SJ, van Aken MO, de Herder WW, Feelders RA, Janssen JA, Badia X, Webb SM, van der Lely AJ (2008) Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant. J Clin Endocrinol Metab 93:3853\u20133859","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR105","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1210\/jc.2011-0654","volume":"96","author":"M Madsen","year":"2011","unstructured":"Madsen M, Poulsen PL, Orskov H, Moller N, Jorgensen JO (2011) Cotreatment with pegvisomant and a somatostatin analog (SA) in SA-responsive acromegalic patients. J Clin Endocrinol Metab 96:2405\u20132413","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR106","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1055\/s-0030-1267244","volume":"119","author":"J Schopohl","year":"2011","unstructured":"Schopohl J, Strasburger CJ, Caird D, Badenhoop K, Beuschlein F, Droste M, Plockinger U, Petersenn S (2011) Efficacy and acceptability of lanreotide Autogel\u00ae 120\u00a0mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR. Exp Clin Endocrinol Diabetes 119:156\u2013162","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"636_CR107","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2265.2003.01710.x","volume":"58","author":"NR Biermasz","year":"2003","unstructured":"Biermasz NR, van den Oever NC, Frolich M, Arias AM, Smit JW, Romijn JA, Roelfsema F (2003) Sandostatin LAR in acromegaly: a 6-week injection interval suppresses GH secretion as effectively as a 4-week interval. Clin Endocrinol (Oxf) 58:288\u2013295","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR108","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","volume":"97","author":"M Fleseriu","year":"2012","unstructured":"Fleseriu M, Biller BM, Findling JW, Molitch ME, Schteingart DE, Gross C (2012) Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing\u2019s syndrome. J Clin Endocrinol Metab 97:2039\u20132049","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR109","doi-asserted-by":"crossref","unstructured":"Katznelson L, Loriaux DL, Feldman D, Braunstein GD, Schteingart DE, Gross C (2013) Global clinical response in Cushing\u2019s syndrome patients treated with mifepristone. Clin Endocrinol (Oxf) 80:562\u2013569","DOI":"10.1111\/cen.12332"},{"key":"636_CR110","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1210\/jc.2012-2477","volume":"97","author":"C Giavoli","year":"2012","unstructured":"Giavoli C, Profka E, Verrua E, Ronchi CL, Ferrante E, Bergamaschi S, Sala E, Malchiodi E, Lania AG, Arosio M, Ambrosi B, Spada A, Beck-Peccoz P (2012) GH replacement improves quality of life and metabolic parameters in cured acromegalic patients with growth hormone deficiency. J Clin Endocrinol Metab 97:3983\u20133988","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR111","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ghir.2006.11.002","volume":"17","author":"J Svensson","year":"2007","unstructured":"Svensson J, Finer N, Bouloux P, Bevan J, Jonsson B, Mattsson AF, Lundberg M, Harris PE, Koltowska-Haggstrom M, Monson JP (2007) Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response. Growth Horm IGF Res 17:67\u201376","journal-title":"Growth Horm IGF Res"},{"key":"636_CR112","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11102-009-0186-y","volume":"12","author":"AA Klaauw van der","year":"2009","unstructured":"van der Klaauw AA, Bax JJ, Roelfsema F, Stokkel MP, Bleeker GB, Biermasz NR, Smit JW, Romijn JA, Pereira AM (2009) Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly. Pituitary 12:339\u2013346","journal-title":"Pituitary"},{"key":"636_CR113","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/jc.2009-1611","volume":"95","author":"KK Miller","year":"2010","unstructured":"Miller KK, Wexler T, Fazeli P, Gunnell L, Graham GJ, Beauregard C, Hemphill L, Nachtigall L, Loeffler J, Swearingen B, Biller BM, Klibanski A (2010) Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab 95:567\u2013577","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR114","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11102-013-0463-7","volume":"17","author":"E Hatipoglu","year":"2013","unstructured":"Hatipoglu E, Topsakal N, Atilgan OE, Alcalar N, Camliguney AF, Niyazoglu M, Cotuk HB, Kadioglu P (2013) Impact of exercise on quality of life and body-self perception of patients with acromegaly. Pituitary 17:38\u201343","journal-title":"Pituitary"},{"key":"636_CR115","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD (2001) Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119:1050\u20131058","journal-title":"Arch Ophthalmol"},{"key":"636_CR116","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/09286586.2014.888456","volume":"21","author":"S Kay","year":"2014","unstructured":"Kay S, Ferreira A (2014) Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores. Ophthalmic Epidemiol 21:66\u201378","journal-title":"Ophthalmic Epidemiol"},{"key":"636_CR117","volume-title":"Self-efficacy: the exercise of control","author":"A Bandura","year":"1997","unstructured":"Bandura A (1997) Self-efficacy: the exercise of control. Freeman, New York"},{"key":"636_CR118","first-page":"695820","volume":"2013","author":"T Haugland","year":"2013","unstructured":"Haugland T, Veenstra M, Vatn MH, Wahl AK (2013) Improvement in stress, general self-efficacy, and health related quality of life following patient education for patients with neuroendocrine tumors: a pilot study. Nurs Res Pract 2013:695820","journal-title":"Nurs Res Pract"},{"key":"636_CR119","first-page":"101","volume-title":"Basic & clinical endocrinology","author":"DG Gardner","year":"2011","unstructured":"Gardner DG, Shoback D (2011) Basic & clinical endocrinology, 9th edn. McGrawHill, Singapore, pp 101\u2013102","edition":"9"},{"key":"636_CR120","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/acta.0.1280301","volume":"128","author":"A Kvistborg","year":"1993","unstructured":"Kvistborg A, Halse J, Bakke S, Bjoro T, Hansen E, Djoseland O, Brownell J, Jervell J (1993) Long-term treatment of macroprolactinomas with CV 205-502. Acta Endocrinol (Copenh) 128:301\u2013307","journal-title":"Acta Endocrinol (Copenh)"},{"key":"636_CR121","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.1997.2701073.x","volume":"47","author":"A Reavley","year":"1997","unstructured":"Reavley A, Fisher AD, Owen D, Creed FH, Davis JR (1997) Psychological distress in patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 47:343\u2013348","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR122","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/EJE-08-0896","volume":"160","author":"C Sievers","year":"2009","unstructured":"Sievers C, Ising M, Pfister H, Dimopoulou C, Schneider HJ, Roemmler J, Schopohl J, Stalla GK (2009) Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls. Eur J Endocrinol 160:367\u2013373","journal-title":"Eur J Endocrinol"},{"key":"636_CR123","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2265.2009.03555.x","volume":"71","author":"C Sievers","year":"2009","unstructured":"Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin Endocrinol 71:691\u2013701","journal-title":"Clin Endocrinol"},{"key":"636_CR124","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1210\/jc.2010-1253","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Biermasz NR, van der Mast RC, Wassenaar MJE, Middelkoop HAM, Pereira AM, Romijn JA (2010) Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly. J Clin Endocrinol Metab 95:E392\u2013E402","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR125","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2010-0512","volume":"95","author":"J Tiemensma","year":"2010","unstructured":"Tiemensma J, Biermasz NR, Middelkoop HAM, van der Mast RC, Romijn JA, Pereira AM (2010) Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing\u2019s disease. J Clin Endocrinol Metab 95:E129\u2013E141","journal-title":"J Clin Endocrinol Metab"},{"key":"636_CR126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2265.2009.03773.x","volume":"73","author":"C Sievers","year":"2010","unstructured":"Sievers C, Brubach K, Saller B, Schneider HJ, Buchfelder M, Droste M, Mann K, Strasburger CJ, Stalla GK (2010) Change of symptoms and perceived health in acromegalic patients on pegvisomant therapy: a retrospective cohort study within the German Pegvisomant Observational Study (GPOS). Clin Endocrinol (Oxf) 73:89\u201394","journal-title":"Clin Endocrinol (Oxf)"},{"key":"636_CR127","doi-asserted-by":"crossref","unstructured":"Andela CD, Niemeijer ND, Scharloo M, Tiemensma J, Kanagasabapathy S, Pereira AM, Kamminga NG, Kaptein AA, Biermasz NR (2014) Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL. Pituitary. doi: 10.1007\/s11102-014-0561-1","DOI":"10.1007\/s11102-014-0561-1"},{"key":"636_CR128","unstructured":"Caglar E, Hatipoglu E, Niyazoglu M, Celik O, Tuncer M, Kadioglu P (2013) Acromegaly is not associated with irritable bowel syndrome: a pilot study. Neuro Endocrinol Lett 34:71\u201374"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-015-0636-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-015-0636-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-015-0636-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T17:37:43Z","timestamp":1717695463000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-015-0636-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,21]]},"references-count":128,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1007\/s11102-015-0636-7","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,21]]}}}